These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34277979)

  • 1. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.
    Carton T; Mathieu E; Wolff F; Bouziotis J; Corvilain B; Driessens N
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00255. PubMed ID: 34277979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of oral contraceptives on overnight 1 mg dexamethasone suppression test.
    Vastbinder M; Kuindersma M; Mulder AH; Schuijt MP; Mudde AH
    Neth J Med; 2016 May; 74(4):158-61. PubMed ID: 27185774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of screening tests for Cushing's syndrome in an overweight and obese population.
    Baid SK; Rubino D; Sinaii N; Ramsey S; Frank A; Nieman LK
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3857-64. PubMed ID: 19602562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
    Görges R; Knappe G; Gerl H; Ventz M; Stahl F
    J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes.
    Steffensen C; Thomsen HH; Dekkers OM; Christiansen JS; Rungby J; Jørgensen JO
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):202-6. PubMed ID: 27028214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?
    Ellis E; Chin PK; Hunt PJ; Lunt H; Lewis JG; Soule SG
    N Z Med J; 2012 Apr; 125(1353):47-58. PubMed ID: 22522271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
    Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
    Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
    Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome.
    Bäcklund N; Brattsand G; Israelsson M; Ragnarsson O; Burman P; Edén Engström B; Høybye C; Berinder K; Wahlberg J; Olsson T; Dahlqvist P
    Eur J Endocrinol; 2020 Jun; 182(6):569-582. PubMed ID: 32213657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.